Stanno regalando le azioni Cell Therapeutics a 0,26 euro!!

certo che il book è bello che incasinato :eek::eek:
 

Allegati

  • ctic_book21.PNG
    ctic_book21.PNG
    10,6 KB · Visite: 3.504
dici che sono solo muretti "dinamici" ??

easycapture1wh.png
 
ecco in azione tucciotrader "Venghino signori venghino....." :rolleyes: :rolleyes: :rolleyes:

3356433794_f006160f6a_z.jpg


..vabbè almeno lo fa di mestiere beato lui.. :cool:
 
ecco in azione tucciotrader "Venghino signori venghino....." :rolleyes: :rolleyes: :rolleyes:

3356433794_f006160f6a_z.jpg


..vabbè almeno lo fa di mestiere beato lui.. :cool:

Le propongo un patto, ma le lascio il tempo per pensare alla risposta...se lei mi dice chi era prima sparisco per sempre dal FOL in generale ;)

Grazie OK!
 
Ormai ci avvicianiamo all'epilogo...e Tuccio è in piena fase catarsica :D

:bow::bow: dal 18 aprile Cell dovrà quotare 1$ in un modo o nell'altro (news, R/S) OK!

L'accordo che gli ultimi istituzionali hanno fatto con la società è di non divulgare notizie ne fare ulteriori ADC ne R/S per 60 giorni, ovvero il 12 marzo ;)

Rimane il mistero sulla società che non ha mai fatto utili ma non è mai fallita fin'ora :mmmm:

Io ci voglio stare dentro OK!
 
:bow::bow: dal 18 aprile Cell dovrà quotare 1$ in un modo o nell'altro (news, R/S) OK!

L'accordo che gli ultimi istituzionali hanno fatto con la società è di non divulgare notizie ne fare ulteriori ADC ne R/S per 60 giorni, ovvero il 12 marzo ;)

Rimane il mistero sulla società che non ha mai fatto utili ma non è mai fallita fin'ora :mmmm:

Io ci voglio stare dentro OK!
Ti capisco caro...è giusto che espii...così troverai la via della redenzione !!:p
 
Segnale Bullish scatenato a breve?? :confused::confused: guardate la media mobile 200 :eek::eek:
 
Ti capisco caro...è giusto che espii...così troverai la via della redenzione !!:p

si si ;)

aragingopedia | Il Cannocchiale blog

Good day, my fine friends. There is a saying that we use when there is confusion. [You can't see the forest because of the trees]Everyone is so involved in watching what Peizer is doing that you do not see what CTI is doing. Don't confuse the two issues. This will turn out great for us in the long run but you must understand that while you are all looking in the wrong direction, shares are being bought at a low price and investors do not see this as an advantage to buy more. And, if and when CTI wins the appeal, the FDA will not respond until June 2011. Yes the FDA has guidlines as well as timelines but to their own soul discretion and this means don't call us we will call you! Take into consideration that the FDA representatives working and communicating at EMEA which will in fact have ongoing open dialogues regarding Pix. This will give you an understanding that FDA will respond in late June and EMEA will respond in late July. You just might see this action happen. Similar to a word called coordination.

Very interesting comments on this board and hang tough during the pps fluctuating in the next few weeks.


g137207suppcov_pg1.jpg


Prospectus Supplement Filed Pursuant to Rule 424(b)(5)


We are subject to a lock-up agreement for a period of 60 days following the date of this prospectus supplement. Pursuant to the lock-up agreement, we have agreed that neither we nor any subsidiary will, without the prior consent of the Initial Purchaser, (i) directly or indirectly, issue, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase or otherwise transfer or dispose of any shares of common stock or any securities convertible into or exercisable or exchangeable for common stock or file any registration statement under the Securities Act (other than a Registration Statement on Form S-8) with respect to any of the foregoing, or (ii) enter into any swap or any other agreement or any transaction that transfers, in whole or in part, directly or indirectly, the economic consequence of ownership of our common stock, whether any such swap or transaction described in clause (i) or (ii) above is to be settled by delivery of common stock or such other securities, in cash or otherwise. However, during the lock-up period, we are permitted to negotiate and/or otherwise prepare to consummate a transaction following the expiration of the lock-up period so long as we do not publicly announce the transaction prior to the expiration of the lock-up period. The lock-up agreement does not apply to (a) the securities to be issued and sold in this offering or issuable upon conversion or exercise of the Series 9 Preferred Stock and warrants, (b) issuances of shares of common stock issuable upon conversion or exchange of currently outstanding convertible notes, (c) issuances of shares of common stock upon the exercise of currently outstanding warrants or amendments to the warrant agreements related thereto, (d) granting options or other securities under our incentive compensation plans existing on the date of this prospectus supplement or issuances of shares of common stock issuable in connection with outstanding awards thereunder as of the date of this prospectus supplement, (e) issuances of shares of common stock issuable pursuant to agreements in effect as of the date of this prospectus supplement or amendments related thereto, (f) issuances of shares of common stock in connection with strategic acquisitions, or (g) issuances of shares of common stock subject to shareholder approval; provided, however, that in the case of clauses (b) and (c) above, no shares of common stock shall be issued as a result of an amendment to such securities after the date of this prospectus supplement and prior to the expiration of the lock-up period.

We have also agreed that for a period of 60 days following the date of this prospectus supplement, we will not, without the prior written consent of the Initial Purchaser, combine (including by way of reverse stock-split) our outstanding shares of common stock into a smaller number of shares or publicly announce our intention to effect a combination, either in a press release, proxy or other regulatory filing or similar notification to the public.

The Securities Purchase Agreement with the Initial Purchaser will be included as an exhibit to a Current Report on Form 8-K that we expect to file with the SEC in connection with this offering.


Insomma, durante questo periodo di lock-up (60 giorni) la società non può emettere nuove azioni ne fare R/S, ne consegue che gli shorter in questo periodo potranno solo chiudere a mercato! ;)
 
si si ;)

aragingopedia | Il Cannocchiale blog

Good day, my fine friends. There is a saying that we use when there is confusion. [You can't see the forest because of the trees]Everyone is so involved in watching what Peizer is doing that you do not see what CTI is doing. Don't confuse the two issues. This will turn out great for us in the long run but you must understand that while you are all looking in the wrong direction, shares are being bought at a low price and investors do not see this as an advantage to buy more. And, if and when CTI wins the appeal, the FDA will not respond until June 2011. Yes the FDA has guidlines as well as timelines but to their own soul discretion and this means don't call us we will call you! Take into consideration that the FDA representatives working and communicating at EMEA which will in fact have ongoing open dialogues regarding Pix. This will give you an understanding that FDA will respond in late June and EMEA will respond in late July. You just might see this action happen. Similar to a word called coordination.

Very interesting comments on this board and hang tough during the pps fluctuating in the next few weeks.


g137207suppcov_pg1.jpg


Prospectus Supplement Filed Pursuant to Rule 424(b)(5)


We are subject to a lock-up agreement for a period of 60 days following the date of this prospectus supplement. Pursuant to the lock-up agreement, we have agreed that neither we nor any subsidiary will, without the prior consent of the Initial Purchaser, (i) directly or indirectly, issue, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase or otherwise transfer or dispose of any shares of common stock or any securities convertible into or exercisable or exchangeable for common stock or file any registration statement under the Securities Act (other than a Registration Statement on Form S-8) with respect to any of the foregoing, or (ii) enter into any swap or any other agreement or any transaction that transfers, in whole or in part, directly or indirectly, the economic consequence of ownership of our common stock, whether any such swap or transaction described in clause (i) or (ii) above is to be settled by delivery of common stock or such other securities, in cash or otherwise. However, during the lock-up period, we are permitted to negotiate and/or otherwise prepare to consummate a transaction following the expiration of the lock-up period so long as we do not publicly announce the transaction prior to the expiration of the lock-up period. The lock-up agreement does not apply to (a) the securities to be issued and sold in this offering or issuable upon conversion or exercise of the Series 9 Preferred Stock and warrants, (b) issuances of shares of common stock issuable upon conversion or exchange of currently outstanding convertible notes, (c) issuances of shares of common stock upon the exercise of currently outstanding warrants or amendments to the warrant agreements related thereto, (d) granting options or other securities under our incentive compensation plans existing on the date of this prospectus supplement or issuances of shares of common stock issuable in connection with outstanding awards thereunder as of the date of this prospectus supplement, (e) issuances of shares of common stock issuable pursuant to agreements in effect as of the date of this prospectus supplement or amendments related thereto, (f) issuances of shares of common stock in connection with strategic acquisitions, or (g) issuances of shares of common stock subject to shareholder approval; provided, however, that in the case of clauses (b) and (c) above, no shares of common stock shall be issued as a result of an amendment to such securities after the date of this prospectus supplement and prior to the expiration of the lock-up period.

We have also agreed that for a period of 60 days following the date of this prospectus supplement, we will not, without the prior written consent of the Initial Purchaser, combine (including by way of reverse stock-split) our outstanding shares of common stock into a smaller number of shares or publicly announce our intention to effect a combination, either in a press release, proxy or other regulatory filing or similar notification to the public.

The Securities Purchase Agreement with the Initial Purchaser will be included as an exhibit to a Current Report on Form 8-K that we expect to file with the SEC in connection with this offering.


Insomma, durante questo periodo di lock-up (60 giorni) la società non può emettere nuove azioni ne fare R/S, ne consegue che gli shorter in questo periodo potranno solo chiudere a mercato! ;)

dai su che non dice che non può fare il reverse, dice che non lo può fare senza il consenso scritto
 
dai su che non dice che non può fare il reverse, dice che non lo può fare senza il consenso scritto dell'istituzionale

vorrei vedere, una volta che l'istituzionale entra che gli fanno il raggruppamento :eek::eek:
 
Indietro